Effects of body weight reduction on plasma leptin and adiponectin/leptin ratio in obese patients with type 1 diabetes mellitus

Physiological Research

Volumn 64, Issue 2, 2015, Pages 221-228

  Musil, F ^a   Blaha, V ^a   Ticha, A ^b   Hyspler, R ^b   Haluzik, M ^c   Lesna, J ^a   Smahelova, A ^a   Sobotka, L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adiponectin; Fasting; Leptin; Obesity; Type 1 diabetes mellitus

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; FATTY ACID; GLUCOSE; LEPTIN;

ADIPOSE TISSUE; ADULT; BLOOD; BODY COMPOSITION; CALORIC RESTRICTION; COMPLICATION; DIET RESTRICTION; DIET THERAPY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; WEIGHT REDUCTION; YOUNG ADULT;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 1; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS; YOUNG ADULT;

EID: 84930154665     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ALDHAHI W, HAMDY O: Adipokines, inflammation, and the endothelium in diabetes. Curr Diab Rep 3: 293-298, 2003.
2. AMITANI M, ASAKAWA A, AMITANI H, INUI A: The role of leptin in the control of insulin-glucose axis. Front Neurosci 7: 51, 2013.
3. AWAD S, CONSTANTIN-TEODOSIU D, MACDONALD IA, LOBO DN: Short-term starvation and mitochondrial dysfunction - a possible mechanism leasing to postoperative insulin resistance. Clin Nutr 28: 497-509, 2009.
4. BECER E, MEHMETÇIK G, BAREKE H, SERAKINCI N: Association of leptin receptor gene Q223R polymorphism on lipid profiles in comparison study between obese and non-obese subjects. Gene 15: 16-20, 2013.
5. BLESSO CN, ANDERSEN CJ, BARONA J, VOLK B, VOLEK JS, FERNANDEZ ML: Effects of carbohydrate restriction and dietary cholesterol provided by eggs on clinical risk factors in metabolic syndrome. J Clin Lipidol 7: 463-471, 2013.
6. BODEN G, CHEN X, MOZZOLI M, RYAN I: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81: 3419-3423, 1996.
7. BURGUERA B, COUCE ME, CURRAN GL, JENSEN MD, LLOYD RV, CLEARY MP, PODUSLO JF: Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49: 1219-1223, 2000.
8. CAMPFIELD LA, SMITH FJ, GUISEZ Y, DEVOS R, BURN P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
9. DEFRONZO RA, TOBIN JD, ANDRES R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223, 1979.
10. DUŠKA F, ANDĚL M, KUBĚNA A, MACDONALD IA: Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus. Clin Nutr 24: 1056-1064, 2005.
11. ELMQUIST JK, ELIAS CF, SAPER CB: From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22: 221-232, 1999.
12. FAROOQI IS, JEBB S, LANGMACK G, LAWRENCE E, CHEETHAM CH, PRENTICE AM, HUGHES IA, MCCAMISH MA, O'RAHILLY S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341: 879-884, 1999.
13. FERRONI P, BASILI S, FALCO A, DAVI G: Inflammation, insulin resistance and obesity. Curr Atheroscler Rep 6:424-431, 2004.
14. FÉRY F, BALASSE EO: Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes 43: 1418-1425, 1994.
15. GALGANI JE, GREENWAY FL, CAGLAYAN S, WONG ML, LICINIO J, RAVUSSIN E: Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. J Clin Endocrinol Metab 95: 851-855, 2010.
16. GERMAN J, KIM F, SCHWARTZ GJ, HAVEL PJ, RHODES CJ, SCHWARTZ MW, MORTON GJ: Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 150: 4502-4511, 2009.
17. HOUSA D, HOUSOVÁ J, VERNEROVÁ Z, HALUZÍK M: Adipocytokines and cancer. Physiol Res 55: 233-244, 2006.
18. HUML M, KOBR J, SIALA K, VARVAŘOVSKÁ J, POMAHAČOVÁ R, KARLÍKOVÁ M, SÝKORA J: Gut peptide hormones and pediatric type 1 diabetes mellitus. Physiol Res 60: 647-658, 2011.
19. INOUE M, MAEHATA E, YANO M, TANIYAMA M, SUZUKI S: Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 54: 281-286, 2005.
20. INOUE M, YANO M, YAMAKADO M, MAEHATA E, SUZUKI S: Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism 55: 1248-1254, 2006.
21. JUNG CH, RHEE EJ, CHOI JH, BAE JC, YOO SH, KIM WJ, PARK CY, MOK JO, KIM CH, LEE WY, OH KW, PARK SW, KIM SW: The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy Korean male adults. Korean Diabetes J 34:237-243, 2010.
22. KALRA SP: Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention? Gene Ther 18: 319-325, 2011.
23. KASTIN AJ, PAN W: Intranasal leptin: blood-brain barrier bypass (BBBB) for obesity? Endocrinology 147: 2086-2087, 2006.
24. KEMMER FW: Prevention of hypoglycemia during exercise in type I diabetes. Diabetes Care 15: 1732-1735, 1992.
25. KILPATRICK ES, RIGBY AS, ATKIN SL: Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: ''double diabetes'' in the diabetes control and complications trial. Diabetes Care 30: 707-712, 2007.
26. KONDO H, SHIMOMURA L, MATSUKAWA Y, KUMADA M, TAKAHASHI M, MATSUDA M, OUCHI N, KIHARA S, KAWAMOTO T, SUMITSUJI S, FUNAHASHI T, MATSUZAWA Y: Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 51:2325-2328, 2002.
27. LIBMAN IM, PIETROPAOLO M, ARSLANIAN SA, LAPORTE RE, BECKER DJ: Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26: 2871-2875, 2003.
28. LIPS MA, PIJL H, VAN KLINKEN JB, DE GROOT GH, JANSSEN IM, VAN RAMSHORST B, VAN WAGENSVELD BA, SWANK DJ, VAN DIELEN F, SMIT JW: Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects. Eur J Endocrinol 169: 339-347, 2013.
29. MANTZOROS CS, MAGKOS F, BRINKOETTER M, SIENKIEWICZ E, DARDENO TA, KIM SY, HAMNVIK OP, KONIARIS A: Leptin in human physiology and pathophysiology. Am J Physiol 301: E567-E584, 2011.
30. MATSUZAWA Y, FUNAHASHI T, KIHARA S, SHIMOMURA I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33, 2004.
31. MEDIANO MF, NEVES FA, CUNHA AC, DE SOUZA EP, MOURA AS, SICHIERI R: Changes in body weight, Creactive protein, and total adiponectin in non-obese women after 12 months of a small-volume, home-based exercise program. Clinics (Sao Paulo) 68: 1121-1127, 2013.
32. MENTE A, RAZAK F, BLANKENBERG S, VUKSAN V, DAVIS AD, MILLER R, TEO K, GERSTEIN H, SHARMA AM, YUSUF S, ANAND SS: Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 33: 1629-1634, 2010.
33. MONZILLO LU, HAMDY O, HORTON ES, LEDBURY S, MULLOOLY C, JAREMA C, PORTER S, OVALLE K, MOUSSA A, MANTZOROS CS: Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11: 1048-1054, 2003.
34. MORA S, PRESSIN JE: An adipocentric view of signalling and intracellular trafficking. Diabetes Metab Res Rev 18:345-356, 2002.
35. MRAZ M, LACINOVA Z, DRAPALOVA J, HALUZIKOVA D, HORINEK A, MATOULEK M, TRACHTA P, KAVALKOVA P, SVACINA S, HALUZIK M: The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 96: 606-613, 2011.
36. MUSIL F, ŠMAHELOVÁ A, BLÁHA V, HYŠPLER R, TICHÁ A, LESNÁ J, ZADÁK Z, SOBOTKA L: Effect of low calorie diet and controlled fasting on insulin sensitivity and glucose metabolism in obese patients with type 1 diabetes mellitus. Physiol Res 62: 267-276, 2013.
37. NEDVÍDKOVÁ J, SMITKA K, KOPSKÝ V, HAINER V: Adiponectin, an adipocyte-derived protein. Physiol Res 54:133-140, 2005.
38. ORCHARD TJ, OLSON JC, ERBEY JR, WILLIAMS K, FORREST KY, SMITHLINE KINDER L, ELLIS D, BECKER DJ: Insulin resistance related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26: 1374-1379, 2003.
39. PALIKHE G, GUPTA R, BEHERA BN, SACHDEVA N, GANGADHAR P, BHANSALI A: Efficacy of laparoscopic sleeve gastrectomy and intensive medical management in obese patients with type 2 diabetes mellitus. Obes Surg 24: 529-535, 2014.
40. PAMBIANCO G, COSTACOU T, ORCHARD TJ: The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30: 1248-1254, 2007.
41. PASARICA M, TCHOUKALOVA YD, HEILBRONN LK, FANG X, ALBU JB, KELLEY DE, SMITH SR, RAVUSSIN E; LOOK AHEAD ADIPOSE RESEARCH GROUP: Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring) 17: 1976-1978, 2009.
42. ROSENBAUM M, GOLDSMITH R, BLOOMFIELD D, MAGNANO A, WEIMER L, HEYMSFIELD S, GALLAGHER D, MAYER L, MURPHY E, LEIBEL R: Low dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 115: 3579-3586, 2005.
43. ROSENBAUM M, HIRSCH J, GALLAGHER D, LEIBEL R: Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr 88: 906-912, 2008.
44. SCHWENK RW, VOGEL H, SCHÜRMANN A: Genetic and epigenetic control of metabolic health. Mol Metab 25:337-347, 2013.
45. THORN LM, FORSBLOM C, FAGERUDD J, THOMAS MC, PETTERSSON-FERNHOLM K, SARAHEIMO M, WADÉN J, RÖNNBACK M, ROSENGÅRD-BÄRLUND M, BJÖRKESTEN CG, TASKINEN MR, GROOP PH: Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28: 2019-2024, 2005.
46. TREMBLAY A, CHAPUT JP: Adaptive reduction in thermogenesis and resistance to lose fat in obese men. Br J Nutr 102: 488-492, 2009.
47. TSAI M, ASAKAWA A, AMITANI H, INUI A: Stimulation of leptin secretion by insulin. Indian J Endocrinol Metab 16 (Suppl 3): S543-S548, 2012.
48. URBANAVIČIUS V, ABALIKŠTA T, BRIMAS G, ABRAITIENE˙ A, GOGELIENE˙ L, STRUPAS K: Comparison of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable gastric banding. Medicina (Kaunas) 49: 9-14, 2013.
49. VEGA GL, GRUNDY SM: Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. J Obes 2013: 409679, 2013.
50. WEYER C, FUNAHASHI T, TANAKA S, HOTTA K, MATSUZAWA Y, PRATLEY RE, TATARANNI PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.